Investigator-initiated Clinical Trial of MIKE-1
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
huCART-meso + VCN-01 in Pancreatic and Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
- Status
- RECRUITING
- Phase
- NA
Cabozantinib and Pembrolizumab in Metastatic Pancreas
- Status
- COMPLETED
- Phase
- PHASE2
CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex)
- Status
- COMPLETED
- Phase
- NA
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- NA
Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
SII And PALBI is Associated With the Prognosis of Pancreatic Cancer Surgery(SII,PALBI)
- Status
- COMPLETED
- Phase
- N/A
Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Status
- RECRUITING
- Phase
- PHASE1
Pancreatic Cancer and Oral Microbiome
- Status
- UNKNOWN
- Phase
- N/A
Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal Irinotecan
- Status
- COMPLETED
- Phase
- N/A
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Status
- RECRUITING
- Phase
- N/A
TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2